https://www.selleckchem.com/products/tmp195.html
After a median follow-up time of 49.0 months, the 5-year BCRF survival rate was 93.3% (95% confidence interval [CI] 91.9-94.8%) among statin users and 88.6% (95% CI 87.1%-90%) among nonusers (log-rank P 0.001). After 10 years, the progression-free survival (PFS) was 91.7% (95% CI 90.1%-93.3%) among statin users and 86.5% (95% CI 84.4%-88.2%) among nonusers (log-rank P 0.001). Extended follow-up data in this large surgical cohort show statin use improves BCRF but not overall survival in RP patients. Extended follow-up data in this
Like
Comment
Share
